91 related articles for article (PubMed ID: 27834087)
1. Accrual to Cancer Clinical Trial.
Kelly C; Smith M; Flynn S; Reyes A; Higgins M; McCaffrey J; Kelly C
Ir Med J; 2016 Aug; 109(7):436. PubMed ID: 27834087
[TBL] [Abstract][Full Text] [Related]
2. Patterns of participation of patients in cancer clinical trials in Ireland.
Morris PG; Kelly R; Horgan A; Nasim S; Kehily D; Grogan L; Breathnach OS
Ir J Med Sci; 2007 Sep; 176(3):153-6. PubMed ID: 17619093
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.
Lara PN; Paterniti DA; Chiechi C; Turrell C; Morain C; Horan N; Montell L; Gonzalez J; Davis S; Umutyan A; Martel CL; Gandara DR; Wun T; Beckett LA; Chen MS
J Clin Oncol; 2005 Dec; 23(36):9282-9. PubMed ID: 16361626
[TBL] [Abstract][Full Text] [Related]
4. Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign.
Umutyan A; Chiechi C; Beckett LA; Paterniti DA; Turrell C; Gandara DR; Davis SW; Wun T; Chen MS; Lara PN
Cancer; 2008 Jan; 112(1):212-9. PubMed ID: 18008353
[TBL] [Abstract][Full Text] [Related]
5. Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.
Tang C; Sherman SI; Price M; Weng J; Davis SE; Hong DS; Yao JC; Buzdar A; Wilding G; Lee JJ
Clin Cancer Res; 2017 Mar; 23(6):1414-1421. PubMed ID: 28275168
[No Abstract] [Full Text] [Related]
6. Accrual issues for chemoprevention trials: the example of the 4-HPR study for the prevention of contralateral breast cancer.
Camerini T; De Palo G; Mariani L; Marubini E; Costa A; Veronesi U
Tumori; 1999; 85(4):299-303. PubMed ID: 10587038
[TBL] [Abstract][Full Text] [Related]
7. Rethinking cancer clinical trials for the future.
Galsky MD
Future Oncol; 2014; 10(9):1545-7. PubMed ID: 25145425
[No Abstract] [Full Text] [Related]
8. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
9. "The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual".
Michaels M; Weiss ES; Guidry JA; Blakeney N; Swords L; Gibbs B; Yeun S; Rytkonen B; Goodman R; Jarama SL; Greene AL; Patel S
J Cancer Educ; 2012 Mar; 27(1):67-74. PubMed ID: 21938600
[TBL] [Abstract][Full Text] [Related]
10. Enrollment in clinical cancer trials: how are we doing and what are the obstacles to improving enrollment rates? A 2-year retrospective review of pediatric cancer trial enrollment in New Zealand.
Dodgshun AJ; De Silva MP; Bradbeer P; Cross S
J Pediatr Hematol Oncol; 2014 Nov; 36(8):630-4. PubMed ID: 24577541
[TBL] [Abstract][Full Text] [Related]
11. Accrual to Trans-Tasman Radiation Oncology Group-sponsored trials 2010-2012.
Christie DR
J Med Imaging Radiat Oncol; 2013 Aug; 57(4):499-502. PubMed ID: 23870351
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial accrual among new cancer patients at a community-based cancer center.
Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
[TBL] [Abstract][Full Text] [Related]
13. What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015-2020).
Jenei K; Haslam A; Olivier T; Miljkovíc M; Prasad V
BMJ Open; 2022 Oct; 12(10):e064458. PubMed ID: 36207035
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Program for the Enhancement of Accrual to Clinical Trials.
Porter M; Ramaswamy B; Beisler K; Neki P; Single N; Thomas J; Hofacker J; Caligiuri M; Carson WE
Ann Surg Oncol; 2016 Jul; 23(7):2146-52. PubMed ID: 26790668
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
[TBL] [Abstract][Full Text] [Related]
16. Comparing attitudes of younger and older patients towards cancer clinical trials.
Ayodele O; Akhtar M; Konenko A; Keegan N; Calacsan F; Duggan L; O'Connor M; Calvert P; Townsley CA; Horgan AM
J Geriatr Oncol; 2016 May; 7(3):162-8. PubMed ID: 27133285
[TBL] [Abstract][Full Text] [Related]
17. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.
Newman LA; Hurd T; Leitch M; Kuerer HM; Diehl K; Lucci A; Giuliano A; Hunt KK; Putnam W; Wells SA
J Am Coll Surg; 2004 Oct; 199(4):644-51. PubMed ID: 15454152
[TBL] [Abstract][Full Text] [Related]
18. Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital.
Karavasilis V; Digue L; Arkenau T; Eaton D; Stapleton S; de Bono J; Judson I; Kaye S
Eur J Cancer; 2008 May; 44(7):978-82. PubMed ID: 18362066
[TBL] [Abstract][Full Text] [Related]
19. Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study.
Hamaker ME; Seynaeve C; Nortier JW; Wymenga M; Maartense E; Boven E; van Leeuwen-Stok AE; de Rooij SE; van Munster BC; Smorenburg CH
Breast; 2013 Aug; 22(4):556-9. PubMed ID: 23305962
[TBL] [Abstract][Full Text] [Related]
20. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
Klabunde C; Kaluzny A; Ford L
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
